The Federal Circuit revived Amarin's heart drug patent lawsuit against Hikma, stating that Hikma's actions may have induced doctors to prescribe a drug violating Amarin's patents. This decision comes after the court reversed a preliminary injunction for trade secret misappropriation and waded into Article III standing in patent cases. Additionally, the court ruled that Section 285 does not allow recovery of fees incurred in IPRs or extend to counsel.
Federal Circuit: Section 285 Does Not Permit Recovery of Fees Incurred in IPRs Nor Does it Extend to Counsel https://t.co/M8Lxrrncqn | by @akin_gump
Federal Circuit: Reverses Motion to Dismiss—Generic Manufacturer’s Label Combined with its Expansive Public Statements Plausibly Induced... https://t.co/A8MXBggZ4Q | by @akin_gump
Employment Law This Week Episode 350 - Spilling Secrets: Protecting Trade Secrets with E-Discovery [Video, Podcast] https://t.co/zHDXHekDxd #employmentlaw #tradesecrets #ediscovery @EpsteinBecker https://t.co/4o3hkZpFxp
[AUDIO] #WorkforceWednesday: Protecting Trade Secrets with E-Discovery - Employment Law This Week® - Spilling Secrets Podcast https://t.co/nIAuFSQYSj | by @ebglaw
The Federal Circuit revived litigation accusing Hikma Pharmaceuticals of inducing physicians to infringe patents covering Amarin Pharma's blockbuster cardiovascular drug Vascepa in a case over limited-use generics. https://t.co/0mJZloak1S
Federal Circuit Wades Into Article III Standing in Patent Cases Once Again https://t.co/9u8jiyeOp1 | by @MoFoLLP
The Federal Circuit revived Amarin's heart drug patent lawsuit against Hikma. The court said that Hikma's generic drug label, along with its press releases and marketing, may have induced doctors to prescribe a drug that violates Amarin's patents https://t.co/smKIJknCFu https://t.co/K5mMSUEu7X
The Basics of Trade Secrets https://t.co/434Cr8gFol | by @fishrichardson
Federal Circuit Reverses Preliminary Injunction for Trade Secret Misappropriation https://t.co/3uvK9Pt4iY | by @lathropgpm
USPTO New Proposed Terminal Disclaimer Practice https://t.co/xwmEpUvEMF | by @arentfoxschiff